Please enable JavaScript to continue using this application.

Compare $CATX vs $OCGN | Chartloom

Compare

$CATX vs $OCGN

Perspective Therapeutics Inc · Ocugen Inc

CATX

Perspective Therapeutics Inc

OCGN

Ocugen Inc

Compare $CATX vs $OCGN

Comparing Perspective Therapeutics Inc and Ocugen Inc

CATXPerspective Therapeutics Inc

OCGNOcugen Inc

CATXPerspective Therapeutics Inc

Market cap

$303M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.9%

YTD performance

-4.7%

52W performance

-31.1%

FCF yield

-40.0%

OCGNOcugen Inc

Market cap

$323M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

181.62x

Rev growth (TTM)

0.4%

YTD performance

-30.8%

52W performance

-46.6%

FCF yield

-18.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CATX

OCGN

Detailed metrics comparison

CATX

Perspective Therapeutics Inc

OCGN

Ocugen Inc

Market Cap

CATX$303M

OCGN$323M

Enterprise Value

CATX$256M

OCGN$308M

Price

CATX$2.66

OCGN$0.96

P/E Ratio

CATXN/A

OCGNN/A

P/S Ratio

CATX741.74x

OCGN67.77x

EV/Sales

CATX627.10x

OCGN64.43x

EV/EBITDA

CATX0.00x

OCGN0.00x

P/B Ratio

CATX0.97x

OCGN59.59x

P/FCF Ratio

CATXN/A

OCGNN/A

EV/FCF

CATX-2.11x

OCGN-5.04x

PEG Ratio

CATXN/A

OCGNN/A

Forward P/E (NTM)

CATXN/A

OCGNN/A

Forward P/S (NTM)

CATXN/A

OCGN181.62x

Revenue (TTM)

CATX$409K

OCGN$5M

Revenue Growth (YoY)

CATX-66.9%

OCGN0.4%

Forward Rev Growth

CATX32.5%

OCGN-47.4%

Gross Margin (TTM)

CATX23.0%

OCGN0.0%

Operating Margin (TTM)

CATX0.0%

OCGN0.0%

EBITDA Margin (TTM)

CATX-29628.1%

OCGN-1043.0%

Net Margin (TTM)

CATX-28468.0%

OCGN-1343.1%

FCF Margin (TTM)

CATX-29657.2%

OCGN-1278.5%

Net Income (TTM)

CATX$-116M

OCGN$-64M

FCF (TTM)

CATX$-121M

OCGN$-61M

EPS (TTM)

CATX-$0.97

OCGN-$0.19

ROE (TTM)

CATX-4156.0%

OCGN-130671.0%

ROA (TTM)

CATX-3413.0%

OCGN-8057.0%

ROIC (TTM)

CATX-4132.0%

OCGN-16519.0%

Cash

CATX$48M

OCGN$100M

Debt

CATX$2M

OCGN$84M

Net Cash/Debt

CATX$47M

OCGN$16M

Current Ratio (TTM)

CATX6.61x

OCGN0.80x

Quick Ratio (TTM)

CATX6.49x

OCGN0.75x

Debt/Equity (TTM)

CATX0.00x

OCGN5.03x

Debt/Assets (TTM)

CATX0.0%

OCGN0.0%

Interest Coverage (TTM)

CATXN/A

OCGNN/A

Net Debt/EBITDA (TTM)

CATX0.00x

OCGN0.00x

Beta

CATX1.87

OCGN1.91

52W Performance

CATX-31.1%

OCGN-46.6%

YTD Performance

CATX-4.7%

OCGN-30.8%

% from 52W High

CATX-56.8%

OCGN-64.9%

% from 52W Low

CATX35.7%

OCGN6.2%

Asset Turnover (TTM)

CATX0.00x

OCGN0.06x

FCF Yield (TTM)

CATX-40.0%

OCGN-18.9%

Earnings Yield (TTM)

CATX-38.4%

OCGN-19.8%

Dividend Yield (TTM)

CATXN/A

OCGNN/A

Rule of 40

CATX-29,724.1

OCGN-1,278.1

EV/GP/RG

CATX22.31

OCGNN/A

Ticker research

View CATX research View OCGN research

Metric	CATX Perspective Therapeutics Inc	OCGN Ocugen Inc
Market & Valuation
Market Cap	$303M	$323M
Enterprise Value	$256M	$308M
Price	$2.66	$0.96
P/E Ratio	N/A	N/A
P/S Ratio	741.74x	67.77x
EV/Sales	627.10x	64.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	59.59x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.11x	-5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	181.62x
Revenue & Growth
Revenue (TTM)	$409K	$5M
Revenue Growth (YoY)	-66.9%	0.4%
Forward Rev Growth	32.5%	-47.4%
Profitability
Gross Margin (TTM)	23.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-29628.1%	-1043.0%
Net Margin (TTM)	-28468.0%	-1343.1%
FCF Margin (TTM)	-29657.2%	-1278.5%
Net Income (TTM)	$-116M	$-64M
FCF (TTM)	$-121M	$-61M
EPS (TTM)	-$0.97	-$0.19
ROE (TTM)	-4156.0%	-130671.0%
ROA (TTM)	-3413.0%	-8057.0%
ROIC (TTM)	-4132.0%	-16519.0%
Financial Health
Cash	$48M	$100M
Debt	$2M	$84M
Net Cash/Debt	$47M	$16M
Current Ratio (TTM)	6.61x	0.80x
Quick Ratio (TTM)	6.49x	0.75x
Debt/Equity (TTM)	0.00x	5.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.87	1.91
52W Performance	-31.1%	-46.6%
YTD Performance	-4.7%	-30.8%
% from 52W High	-56.8%	-64.9%
% from 52W Low	35.7%	6.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-40.0%	-18.9%
Earnings Yield (TTM)	-38.4%	-19.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-29,724.1	-1,278.1
EV/GP/RG	22.31	N/A
Ticker research	View CATX research	View OCGN research

Valuation

P/S Ratio

OCGN

67.77x

CATX

741.74x

EV/FCF

OCGN

-5.04x

CATX

-2.11x

Growth & revenue

Revenue Growth TTM

OCGN

0.4%

CATX

-66.9%

Forward Revenue Growth

CATX

32.5%

OCGN

-47.4%

Profitability & performance

Gross Margin

CATX

23.0%

OCGN

0.0%

ROE

CATX

-4156.0%

OCGN

-130671.0%

FCF Yield %

OCGN

-18.9%

CATX

-40.0%

52-Week Performance

CATX

-31.1%

OCGN

-46.6%

Detailed metrics comparison

CATX

Perspective Therapeutics Inc

OCGN

Ocugen Inc

Market Cap

CATX$303M

OCGN$323M

Enterprise Value

CATX$256M

OCGN$308M

Price

CATX$2.66

OCGN$0.96

P/E Ratio

CATXN/A

OCGNN/A

P/S Ratio

CATX741.74x

OCGN67.77x

EV/Sales

CATX627.10x

OCGN64.43x

EV/EBITDA

CATX0.00x

OCGN0.00x

P/B Ratio

CATX0.97x

OCGN59.59x

P/FCF Ratio

CATXN/A

OCGNN/A

EV/FCF

CATX-2.11x

OCGN-5.04x

PEG Ratio

CATXN/A

OCGNN/A

Forward P/E (NTM)

CATXN/A

OCGNN/A

Forward P/S (NTM)

CATXN/A

OCGN181.62x

Revenue (TTM)

CATX$409K

OCGN$5M

Revenue Growth (YoY)

CATX-66.9%

OCGN0.4%

Forward Rev Growth

CATX32.5%

OCGN-47.4%

Gross Margin (TTM)

CATX23.0%

OCGN0.0%

Operating Margin (TTM)

CATX0.0%

OCGN0.0%

EBITDA Margin (TTM)

CATX-29628.1%

OCGN-1043.0%

Net Margin (TTM)

CATX-28468.0%

OCGN-1343.1%

FCF Margin (TTM)

CATX-29657.2%

OCGN-1278.5%

Net Income (TTM)

CATX$-116M

OCGN$-64M

FCF (TTM)

CATX$-121M

OCGN$-61M

EPS (TTM)

CATX-$0.97

OCGN-$0.19

ROE (TTM)

CATX-4156.0%

OCGN-130671.0%

ROA (TTM)

CATX-3413.0%

OCGN-8057.0%

ROIC (TTM)

CATX-4132.0%

OCGN-16519.0%

Cash

CATX$48M

OCGN$100M

Debt

CATX$2M

OCGN$84M

Net Cash/Debt

CATX$47M

OCGN$16M

Current Ratio (TTM)

CATX6.61x

OCGN0.80x

Quick Ratio (TTM)

CATX6.49x

OCGN0.75x

Debt/Equity (TTM)

CATX0.00x

OCGN5.03x

Debt/Assets (TTM)

CATX0.0%

OCGN0.0%

Interest Coverage (TTM)

CATXN/A

OCGNN/A

Net Debt/EBITDA (TTM)

CATX0.00x

OCGN0.00x

Beta

CATX1.87

OCGN1.91

52W Performance

CATX-31.1%

OCGN-46.6%

YTD Performance

CATX-4.7%

OCGN-30.8%

% from 52W High

CATX-56.8%

OCGN-64.9%

% from 52W Low

CATX35.7%

OCGN6.2%

Asset Turnover (TTM)

CATX0.00x

OCGN0.06x

FCF Yield (TTM)

CATX-40.0%

OCGN-18.9%

Earnings Yield (TTM)

CATX-38.4%

OCGN-19.8%

Dividend Yield (TTM)

CATXN/A

OCGNN/A

Rule of 40

CATX-29,724.1

OCGN-1,278.1

EV/GP/RG

CATX22.31

OCGNN/A

Ticker research

View CATX research View OCGN research

Metric	CATX Perspective Therapeutics Inc	OCGN Ocugen Inc
Market & Valuation
Market Cap	$303M	$323M
Enterprise Value	$256M	$308M
Price	$2.66	$0.96
P/E Ratio	N/A	N/A
P/S Ratio	741.74x	67.77x
EV/Sales	627.10x	64.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	59.59x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.11x	-5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	181.62x
Revenue & Growth
Revenue (TTM)	$409K	$5M
Revenue Growth (YoY)	-66.9%	0.4%
Forward Rev Growth	32.5%	-47.4%
Profitability
Gross Margin (TTM)	23.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-29628.1%	-1043.0%
Net Margin (TTM)	-28468.0%	-1343.1%
FCF Margin (TTM)	-29657.2%	-1278.5%
Net Income (TTM)	$-116M	$-64M
FCF (TTM)	$-121M	$-61M
EPS (TTM)	-$0.97	-$0.19
ROE (TTM)	-4156.0%	-130671.0%
ROA (TTM)	-3413.0%	-8057.0%
ROIC (TTM)	-4132.0%	-16519.0%
Financial Health
Cash	$48M	$100M
Debt	$2M	$84M
Net Cash/Debt	$47M	$16M
Current Ratio (TTM)	6.61x	0.80x
Quick Ratio (TTM)	6.49x	0.75x
Debt/Equity (TTM)	0.00x	5.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.87	1.91
52W Performance	-31.1%	-46.6%
YTD Performance	-4.7%	-30.8%
% from 52W High	-56.8%	-64.9%
% from 52W Low	35.7%	6.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-40.0%	-18.9%
Earnings Yield (TTM)	-38.4%	-19.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-29,724.1	-1,278.1
EV/GP/RG	22.31	N/A
Ticker research	View CATX research	View OCGN research